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Astrogliosis in a dish: substrate stiffness induces
astrogliosis in primary rat astrocytes†
Christina L. Wilson,a Stephen L. Haywarda and Srivatsan Kidambi*abcde
Astrogliosis due to brain injury or disease can lead to varying molecular and morphological changes in
astrocytes. Magnetic resonance elastography and ultrasound have demonstrated that brain stiffness
varies with age and disease state. However, there is a lack in understanding the role of varied stiffness on
the progression of astrogliosis highlighting a critical need to engineer in vitro models that mimic disease
stages. Such models need to incorporate the dynamic changes in the brain microenvironment including
the stiffness changes. In this study we developed a polydimethyl siloxane (PDMS) based platform that
modeled the physiologically relevant stiffness of brain in both a healthy (200 Pa) and diseased (8000 Pa)
state to investigate the effect of stiffness on astrocyte function. We observed that astrocytes grown on
soft substrates displayed a consistently more quiescent phenotype while those on stiff substrates
displayed an astrogliosis-like morphology. In addition to morphological changes, astrocytes cultured on
stiff substrates demonstrated significant increase in other astrogliosis hallmarks – cellular proliferation
and glial fibrillary acidic protein (GFAP) protein expression. Furthermore, culturing astrocytes on a stiff
surface resulted in increased reactive oxygen species (ROS) production, increased super oxide dismutase
activity and decreased glutamate uptake. Our platform lends itself for study of potential therapeutic
strategies for brain injury focusing on the intricate brain microenvironment-astrocytes signaling pathways.
Introduction
The brain is a mechanically heterogeneous organ that utilizes
endogenous mechanical forces to regulate aspects of the tissue
and cellular function. Magnetic resonance elastography, ultra-
sound and mechanical compression techniques have demon-
strated that stiffness of brain regions vary1,2 and these
mechanical properties substantially change with age and
disease state.3–7 Although endogenous micromechanical energy
is important for normal brain function, substantially greater
mechanical forces acting on the brain can result in loss of
consciousness, irreversible cognitive dysfunction, progressive
neurodegeneration and even death.8–10 Numerous studies have
focused on the deleterious consequences of brain injury and
disease, however, the host of deleterious molecular signaling
pathways triggered as cellular-mechanical consequences of
head trauma and the underlying mechanisms of these injuries
are still not clear. Several studies have demonstrated that the
mechanical microenvironment of a cell inuences key aspects
of cell functionality and structure.11–16 Hence, it is critical to
investigate the role of varied stiffness on cellular function.
The classically accepted paradigm regards neurons as the
major player associated with brain function in normal and
diseased states. Astrocytes – the most abundant cell type in the
brain – have largely been considered as supporting cells for
neurons that provide an ideal environment for neuronal-cell
function but have no direct role in brain activity. However,
accumulating evidence has challenged this paradigm to suggest
that astrocytes are sophisticated participants in a diverse variety
of functions for normal brain development and activity.17–21
Studies have also implicated astrocytes to play an important
role in the progression of several neurodegenerative diseases,
including, Alzheimer's disease (AD), Parkinson’ disease, Down
syndrome, Amyotrophic lateral sclerosis and epilepsy.22–26
Astrogliosis/reactive astrocytosis is marked by an abnormal
increase in the number of astrocytes frequently observed in
brain trauma, infection, stroke, and neurodegenerative
diseases.27 This process involves activation of astrocytes leading
to production of proinammatory mediators such as cytokines,
chemokines, glutamate, reactive oxygen species (ROS), and
prostanoids.28,29 During astrogliosis, astrocytes become hyper-
trophic with up-regulated expression of intermediate laments
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(e.g. glial brillary acidic protein (GFAP), vimentin), oxidative
stress markers, and cytokines. Advanced astrogliosis ultimately
leads to formation of glial scar as a physical barrier, which can
inhibit axonal regeneration.30 Reactive astrocytosis is not merely
a marker for neuropathology, but plays an essential role in
orchestrating injury response, regulating inammation and
overall tissue repair that markedly impacts functional and
clinical outcomes. While there has been reasonable progress
toward understanding astrocyte physiology, little is known
about the effect of changes in brain microenvironment,
including stiffness, in mediating astrogliosis.
In our study, we utilized a polydimethyl siloxane (PDMS)
based substrate with tunable stiffness to study the effect of
various degrees of stiffness on the phenotype of primary rat
cortical astrocytes. Our working hypothesis is that variation in
matrix stiffness will inuence astrocyte phenotype and func-
tion, and that astrocytes will subsequently develop astrogliosis-
like responses to mechanical perturbation. We employed a so
substrate (200 Pa) to represent healthy brain tissue and stiff
substrate (8000 Pa) to represent diseased brain tissue as these
fall in the range of previous in vivo and in vitro investigations
into brain stiffness and the effect of changing brain stiff-
ness.2,3,31–33 We studied the effect of stiffness on commonly
accepted hallmarks of astrogliosis including changes in cell
morphology, proliferation, expression of vimentin and GFAP.
Further we characterized the effect of stiffness on glutamate
uptake, an important function of astrocytes, and perturbation
of cellular oxidative state induced by the surface stiffness. Our
observations indicate a strong dependence of primary astro-
cytes function on the culture substrate stiffness thus demon-
strating a potential pathway for the progression of astrogliosis.
Materials and methods
Substrate characterization
CytoSo® 6-well plates of stiffness measured to be elastic
modulus 200 Pa and 8000 Pa were purchased from Advanced
BioMatrix. Extensive property testing was performed by
Advanced BioMatrix to assure the quality of surfaces. Surfaces
were coated with poly-L-lysine (PLL) prior to cell seeding
according to manufacturer instructions. Florescent images of
carboxyuorescein treated PLL surfaces (N ¼ 3) were imaged
and the uorescence intensity quantied by Image J Analysis
Soware [NIH] to demonstrate the uniformity of substrate
coating is not varied by substrate stiffness.
Isolation and culture of primary astrocytes
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Labo-
ratory Animals of the National Institutes of Health. The protocol
was approved by the Committee on the Ethics of Animal
Experiments of the University of Nebraska-Lincoln (Project ID:
1046). Primary cortical astrocytes were prepared from 1–3 day-
old Sprague-Dawley rat pups [Charles River] in compliance
with UNL's IACUC protocol 1046 and according to protocol with
slight modications.34,35 In short, the tissue was dissociated
with 0.25% Trypsin–EDTA [Life Technologies] and 0.016%
DNase [Roche] which was quenched by serum containing
culture media (DMEM [MP Biomedicals], 10% fetal bovine
serum [Atlanta Biologicals], and 1% penicillin–streptomycin
[Life Technologies]). The trypsin was removed by centrifugation
at 1700 rpm for 5 min aer which the pellet was suspended in
media and gently homogenized with glass pipette. The
homogenate was then passed through a 70 mm cell lter, pel-
leted, suspended in media and seeded on tissue culture Petri
dish. On day in vitro (DIV) two the Petri dish was vigorously
shaken to remove loosely attached cells, mostly neurons and
microglia, and media was exchanged for fresh media. The
vigorous shaking was repeated prior to each media change and
passaging to remove any remaining loosely attached cells,
including microglia. This method is used to remove contami-
nating glia from primary mixed cultures as described in Tam-
ashiro et al. and Cole et al.36,37 Cultures were characterized by
uorescent microscopy using anti-glial brillary acidic protein
(GFAP) [DAKO] and 40,6-diamidino-2-phenylindole (DAPI)
nuclear stain [Thermo Scientic] yielding cultures of >90%
GFAP positive cells (ESI Fig. 3†).
Experimental culture
Astrocytes received media changes every three days until 70–
80% conuent (DIV 6) at which point the cells were passaged by
dissociation with 0.5% Trypsin–EDTA [Life Tech], quenched
with culture media, pelleted, suspended in culture media and
seeded in tissue culture dish at three million cells per dish.
Cultures were allowed to expand with media changed every
three days until conuent two times. Passage three astrocytes
were seeded for experiments on PLL coated CytoSo® 6-well
plates of stiffness measured to be 200 Pa and 8000 Pa [Advanced
BioMatrix].
Phase images
Phase images were obtained for morphology of live cells
assessment using an Axiovert 40 CFL [Zeiss] and Progres C3
[Jenoptick] camera.
Actin staining, cell size and circularity
Cells were xed with 4% paraformaldehyde in PBS at room
temperature for 20 min. Samples were permeabilized in 0.2%
Triton X-100 for 15 min at room temperature. Actin 488
ReadyProbes [Life Technology] was applied according to
manufacturer instructions and incubated on xed cells at room
temperature for 30 min. Nuclei were visualized with DAPI stain
by a 5 min incubation at room temperature in a 1 mg ml1
solution. Images were obtained using Axiovert 40 CFL [Zeiss]
and a Progres C3 [Jenoptick] camera with an X-Cite series 120Q
[Lumen Dynamics] lamp utilizing FITC or DAPI lter [Chroma].
Actin images were assessed for average cell area and circularity
utilizing the measure feature of NIH Image J. Ten random cells
per image were highlighted and quantied for cell area and
circularity. Cell area was reported as a fraction of the average
cell size on 200 Pa surface. Cell circularity was reported in
arbitrary units between 0 and 1 with a perfect circle ranking 1.
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Western blot
Whole cell lysates were collected using a RIPA buffer (PBS, pH
7.4, 1% CA 630 IGEPAL, 0.5% deoxycholate, 0.1% sodium
dodecyl sulfate, protease inhibitor cocktail and phenyl-
methylsufonyl uoride) [Sigma Aldrich]. Proteins were quanti-
ed using coomassie blue [Thermo Scientic Kit 23200]. 10–50
mg of total protein was separated by 10% SDS-polyacrylamide gel
electrophoresis and transferred to Immobilon FL membrane
[Millipore] using transfer buffer (25 mM Tris, 192 mM glycine,
10% methanol) and detected with primary antibodies (GAPDH
[Millipore], GFAP [DAKO], EAAT1 [Abcam], EAAT2 [Abcam] and
vimentin [GeneTex]) followed by Dylight 800 polyclonal
secondary antibody [Thermo Scientic] and imaged with an
Odyssey FC [LiCor].
BrdU staining
Proliferation was assessed utilizing 5-bromo-2-deoxyuridine
(BrdU) which incorporates into newly formed DNA during
proliferation and is then detectable by Alexa Fluor 488 conju-
gated antibody [Life Technology]. This was performed by rst
incubating the astrocyte monolayer in 10 mM BrdU in culture
media solution for 24 h at 37 C prior to xing the cells in
a suspension of 4% paraformaldehyde. The cells were per-
meabilized with 0.1% Triton X-100 in PBS, DNA denatured with
0.03% DNase in PBS, and blocked with 1% BSA in PBS. Finally,
the BrdU was detected by incubating the cells in anti-BrdU
antibody [Life Technology] in 1% BSA in PBS overnight at 4
C, washed two times in 1 PBS and orescence intensity
quantied by FACS Cantoll (BD) in the green channel (ex. 495,
em. 520; 100 000 total events/read) against cells not treated with
BrdU.
ROS generation
5-(and-6)-Chloromethyl-20,70-dichlorodihydrouorescein diac-
etate (CM-H2DCFDA) is a uorescent indicator activated by the
presence of ROS. The intensity of CM-H2DCFDA was quantied
using a FACS Cantoll (BD). Culture media was aspirated and the
cells washed with warm PBS. 10 mM CM-H2DCFDA [Life Tech-
nologies] in DMEM was added to each well and incubated at 37
C for 30 min. Cells were washed three times with PBS, trypsi-
nized, transferred to DMEM in ow cytometry tubes and
analyzed for uorescence in the green channel (ex. 495, em. 520;
100 000 total events/read) against cells not treated with CM-
H2DCFDA.
Superoxide dismutase activity
The activity of CuZnSOD was measured by in gel reduction of
nitroblue tetrazolium method described in Natarajan et al. with
some modications.38 First, proteins were lysed in a buffer
consisting of 50 mM NaCl, 5 mM EDTA, 0.1% Triton X-100 and
protease inhibitor. Next the protein was quantied by BCA assay
and samples containing 30 mg protein made with loading dye
consisting of 25 mM Tris–HCl (6.8), 50% glycerol, 0.5% bro-
mophenol blue. A 12% bis-acrylamide gel without SDS was
utilized with a running buffer consisting of 0.2 M glycine, 0.02
M Trizma and 0.01M EDTA. Aer samples were separated by gel
electrophoresis the gel was removed and incubated for 30 min
in staining solution (0.05 M K2HPO4, 0.005 M KH2PO4, 0.16 mM
nitroblue tetrazolium, 0.26 mM riboavin and 0.1% TEMED).
The gel was then washed, suspended in DI water and incubated
in ambient light overnight. Images were obtained utilizing
Quantity One Analysis Soware [Biorad] and quantied via
Studiolite [Lycor].
Glutamate uptake
The uptake of [3H]-glutamic acid was used to determine change
in glutamate uptake experienced by astrocytes on so and stiff
surface. The media was removed and replaced by serum free
high glucose DMEM containing 50 mM glutamate and 18.5 kBq
of [3H]-glutamic acid [Perkin Elmer] which was allowed to
incubate at 37 C of 15 min. Uptake was terminated by removal
of working solution and cells washed twice with ice-cold PBS
lysed in 10 mM NaOH containing 0.1% Triton X-100. 300 ml of
lysate was added to liquid scintillation cocktail [Fisher Scien-
tic] and quantied by counting. The protein content was
assayed using Bradford assay [Thermo Scientic Kit 23200].
Results were reported as CPM per mg protein.
Gene expression
Total RNA expression was quantied by quantitative real time
PCR as described previously.39 Primers were obtained from
Integrated DNA Technologies [Coralville, IA] of the following
sequences: vimentin (forward 50-GACAATGCGTCTCTGG
CACGTCTT-30 and reverse 50-TCCTCCGCCTCCTGCAGGTTCTT-
30), GLAST (forward 50-CTACTCACCGTCAGCGCTGT-30 and
reverse 50-AGCACAAATCTGGTGATGCG-30) and GLT1 (forward
50-CCCAAGTACGAAGGGACAATTA-30 and reverse 50-CTCATC
CACAGTCCACATCTTC-30). Expressions were found relative to
housekeeping gene GAPDH (forward 50-ATGATTCTACC
CACGGCAAG-30 and reverse 50-CTGGAAGATGGTGATGGGTT-30)
utilizing the DDCT method. Final results were reported as
normalized to the average relative expression on the so
surface.
Statistical analysis
All data is presented as the mean  the standard deviation.
Statistical comparisons between treatments utilized sigma plot
Student T-test and pool size as indicated. For data, which did
not follow a Gaussian distribution, a Mann–Whitney rank test
was employed with pool size as indicated.
Results
Stiffness induces astrogliotic morphology and actin stress
bers
To determine if altering the physical stress experienced on the
cellular level could induce an astrogliosis-like morphology, we
isolated primary astrocytes and cultured the cells on PLL coated
PDMS substrates of varied stiffness (Fig. 1). We observed at 72 h
primary astrocytes displayed smaller, rounded morphology on
200 Pa (so) substrates and larger, elongated morphology on
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 34447–34457 | 34449
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8000 Pa (stiff) substrates (Fig. 1). The morphology on stiffer
substrate is akin to the astrocytes morphology observed in vivo
during astrogliosis27 with more process extensions and
increased surface area. To assure that this observed phenomena
was not a result of heterogeneous PLL coating, we measured the
uorescent intensity of adsorbed carboxyuorescein on PLL
coated so and stiff surfaces and found surface coating
uniformity on both substrates (ESI Fig. 1†). We further investi-
gated the effect of stiffness on cell morphology by
immunostaining the actin cytoskeletal structure (Fig. 2A).
Similar to the phase images, astrocytes on 200 Pa substrates had
a rounded morphology with smaller cell bodies while the
morphology substantially changed when cultured on 8000 Pa
substrates possessing larger cell bodies and stretched
morphology. Quantication revealed the average cell size on the
stiff surface covered 1.6 (P < 0.05) times the surface area of the
average cell cultured on the so surface (Fig. 2B). Furthermore
cells on the so surface had a circularity rank of 0.43 while cells
Fig. 1 Schematic of experimental design. Primary rat astrocytes were isolated from day 1–3 rat pups. Culture purity was determined to be >90%
GFAP positive cells by immunocytochemistry. Cells were seeded on PLL coated Cytosoft® 6 well plates with physiologically relevant stiffness
(200 Pa per soft mimics healthy brain tissue and 8000 Pa per stiffmimics diseased/injured brain tissue). After three days in culture, the phenotypic
markers and changes in morphology of primary astrocytes were assessed to demonstrate astrogliosis like behavior in astrocytes when cultured
on stiff substrates. Scale bar 100 mm. Figure drawn by Christina L Wilson.
Fig. 2 Change in cell morphology reveals activation on soft (200 Pa) vs. stiff (8000 Pa) surfaces. (A) Representative images of astrocyte
morphology visualized with actin staining. White arrow indicates distinct actin stress fibers not seen on the soft surface. Scale bar 100 mm. (B) Cell
size and (C) circularity quantification of actin images utilized NIH Image J. N ¼ 4, “*” indicates P < 0.05.
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on the stiff surface has a circularity rank of 0.21 (P < 0.05),
quantifying that astrocytes on the so surface had rounded
morphology (Fig. 2C). This observation is similar to other
studies that have demonstrated astrocytes were less branched,
more rounded and had quiescent morphology on surfaces
between 100 and 300 Pa while astrocytes had more branching,
covering more surface area on surfaces greater than 1000
Pa.33,40,41 We also observed a dramatic increase in actin organi-
zation and cell polarizability on stiffer (8000 Pa) surfaces. This
has been observed in other cells and is generally known as
actomyosin bundles or stress bers.42–44
Stiffness increases astrocytes proliferation
Studies have demonstrated that astrogliosis results in the
increase of astrocytes present in damaged areas by induction of
astrocyte proliferation.27 We investigated the effect of stiffness
on astrocytes proliferation on so (200 Pa) and stiff (8000 Pa)
substrates using BrdU staining (Fig. 3A). We observed that
astrocytes on stiff substrates had a 1.7 fold increase (P < 0.05) in
BrdU staining compared to those on so substrates aer 72
hours in culture. In our study we utilized BrdU assay and ow
cytometry to quantify the phenotypic change independent of
cell number. BrdU assay measured the incorporation of BrdU in
replicating DNA early in mitotic cell cycle due to proliferation
and ow cytometry allowed for the quantication on a per cell
basis evaluating the average orescent intensity of 10 000 cells.
Therefore our data demonstrated that the changes in brain
stiffness might be one of the potential causes for the increase in
astrocytes during brain injury.
Stiffness induces up-regulation of GFAP expression
We next investigated the effect of stiffness on GFAP protein
expression, an intermediate lament expressed exclusively by
astrocytes. Increase in GFAP protein expression is a clinical
hallmark sign of astrogliosis both in vivo and in vitro.27,45 A 1.3
fold up-regulation (P < 0.05) in GFAP protein expression (Fig. 3B)
was observed in astrocytes cultured on stiff substrates (8000 Pa)
compared to so substrates (200 Pa). Further, we probed the
effect of stiffness on the protein expression of a less recognized
intermediate gliolament, vimentin, which has also been
observed to increase in astrogliosis and found no up-regulation
in protein expression (Fig. 3B) in primary astrocytes cultured on
stiff substrates compared to so substrates. As gene expression
proceeds protein expression, and can be used as an early indi-
cation of phenotypic change, to further probe the vimentin
expression RT-PCR was utilized to quantify gene expression.46–48
It was observed that vimentin gene expression (ESI Fig. 2†) was
up-regulated 1.6 fold (P < 0.05) indicating a temporally sensitive
effect of substrate stiffness on vimentin expression. Although
increase in GFAP and vimentin expression have been extensively
used as astrogliosis markers in vivo and in vitro, studies in
vimentin knock-out mice have shown that vimentin up-
regulation is not required for induction of astrogliosis.49 This
observation, in combination with the previous results, supports
Fig. 3 Culture on stiff substrate induces increase in cell proliferation and up-regulation of astrogliosis markers. (A) Quantification of BrdU
incorporation by flow cytometry N ¼ 3. (B) Quantification of GFAP and vimentin protein expression, N ¼ 4 or 5. “*” P < 0.05.
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our hypothesis that astrocytes cultured in environment with
increased stiffness induce astrogliosis in vitro.
Stiffness increases ROS production and SOD activity in
primary astrocytes
Animals and other experimental models have demonstrated that
specic signaling cascades including production and release of
toxic levels of ROS might stimulate astrogliosis.50–52 Utilizing
H2DCFDA and ow cytometry we quantied the effect of stiffness
on generation of intercellular levels of ROS when primary astro-
cytes were cultured in either a healthy or a stiff diseased-like
environment (Fig. 4A). A 9-fold increase (P < 0.001) in intercel-
lular ROS production was observed in astrocytes cultured on stiff
substrates compared to so substrates. This is a signicant
nding as animal studies have demonstrated that chronic neu-
orinammation and neurodegeneration associated withmassive/
prolong brain injury or astrocyte stress leads to amplication of
a microglia-astrocyte crosstalk and uncontrolled release of
ROS.50–52 Our model demonstrates that primary astrocytes
cultured on stiffer substrate experience increase in ROS levels
similar to the transition observed in the animal injury models.
The uncontrolled increase in ROS can lead to oxidative stress
and cellular damage if not countered by the activity of endog-
enous anti-oxidant species as has been seen in a number of
toxicology and neurodegenerative disease studies.38,53,54
Copper–zinc super oxide dismutase (CuZnSOD) is an endoge-
nous anti-oxidant which targets the reduction of super oxide
species into peroxide to alleviate oxygen radicals and protect the
cell from oxidative stress.55 The CuZnSOD activity wasmeasured
(Fig. 4B) utilizing an in gel NBT reduction assay and found to be
increased by 1.5 fold (P < 0.05) in astrocytes cultured on the 8000
Pa surface compared to the astrocytes on 200 Pa PDMS. These
result demonstrate the ability of this model to follow the
adaptive oxidative state pathways of reactive astrocytes which
could increase understanding of the astrogliotic phenotype and
uncover potential therapeutic methods.
Stiffness induces loss in glutamate uptake in primary
astrocytes
Glutamate uptake is a paramount function of astrocytes in
proper brain activity. Consequently, we investigated the effect
of stiffness induced astrogliosis phenotype on the regulation
Fig. 4 Culture on stiff substrate results in generation of ROS in primary astrocytes. (A) Quantification of ROS generation using H2DCFDA based
fluorescence assay and flow cytometry, N ¼ 3. (B) Quantification of CuZnSOD by in gel activity assay, N ¼ 3 or 4. “*” indicates P < 0.05 and “**”
indicates P < 0.001.
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of the glutamate uptake mechanism in astrocytes (Fig. 5). We
rst quantied the overall functionality of glutamate transport
and observed a 2-fold decrease (P < 0.05) in glutamate uptake
in primary astrocytes cultured on stiff substrates compared to
those on so. To elicit the cause of glutamate uptake loss, we
next quantied the gene and protein expression of key gluta-
mate transporters in relation to substrate stiffness. Five
subtypes of glutamate transporters have been identied in
rodents and humans including glutamate/asparate trans-
porter (GLAST) and glutamate transporter 1 (GLT1) as the
transporters predominately expressed in astrocytes and
required for regulating the glutamate uptake in the brain.56
Therefore, we quantied the relative GLAST and GLT1 gene
expression following culture on so and stiff surfaces as
changes in gene expression may be an early indication of
transporter protein alteration. Although GLAST expression
remained similar on the varied surfaces, GLT1 expression was
signicantly increased (1.4 fold, P < 0.05) on the 8000 Pa
surface (Fig. 5B). Furthermore, we quantied GLT1 and GLAST
protein expression to indicate if the change in gene expression
was followed similarly to the change in protein expression.
The quantication of protein expression indicated no change
in GLT1 or GLAST protein expression (Fig. 5C) conrming that
the alteration in glutamate uptake was not a result of altered
transporter expression resulting from culture surface stiffness.
This data is useful to provide insight to the current pool of
understanding on glutamate homeostasis and variation in
tissue stiffness.
Discussion
Astrogliosis/reactive astrocytes are a prominent and ubiquitous
reaction of astrocytes to many forms of brain injury, oen
implicated in the poor regenerative capacity of the central
nervous system (CNS). Reactive astrogliosis is associated with
new gene expression or up-regulation of molecules that are at
low levels in quiescent astrocytes.27,57,58 However, little is known
about the structural and molecular mechanisms underlying the
transformation of astrocytes to the reactive state. Furthermore,
there are currently no comprehensive proles of brain injury-
initiated protein changes in reactive astrocytes.
Animal models such as stab wound-induced brain injury,
neurotoxic lesions, genetic diseases (twitcher mouse) and
inammatory demyelination (experimental allergic encephalo-
myelitis) have been extensively used to investigate the progres-
sion of astrogliosis.59 However, in vivo models have numerous
drawbacks including: (1) the challenge associated with mecha-
nistic study of reactive astrogliosis induction, (2) difficulties in
reproducing the same extent of injuries in multiple experi-
ments, (3) interference of systemic response to trauma in
specic cellular effect and (4) inability to identify biochemical
properties of reactive astrocytes.60
In vitro models allow the investigation of an isolated
phenomenon in a well-dened environment, which is free from
complex cellular interactions. Established astrogliosis in vitro
models include in vitro mechanical injury model (e.g. scratch
wound, platform stretch),61,62 low temperature trauma model,63
Fig. 5 Effect of stiff substrates on glutamate uptake. (A) Glutamate uptake of radiolabeled glutamate by astrocytes on soft and stiff surfaces. (B)
RT-PCR gene expression quantification of glutamate transporters, GLAST and GLT1, on soft and stiff surfaces, N ¼ 3. (C) Western blot quanti-
fication of protein expression of glutamate transporters, GLT1 and GLAST, on soft and stiff surfaces, N ¼ 4. “*” P < 0.05.
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 34447–34457 | 34453
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and addition of growth factors to astrocyte cultures.64,65
However, these methods result in heterogeneous population of
injured and uninjured cells resulting in varying gene and
protein expression changes in astrocytes. Furthermore, these
models do not facilitate the understanding of themolecular and
cellular properties of astrocytes resulting from extended, static
mechanical change in brain microenvironment, such as that
resulting from swelling or change in microenvironment
composition, and how they regulate the functional astrocytes.
There is a critical need for an in vitro injury model to be able to
investigate the molecular changes in astrocytes systematically
and quantitatively in a reproducible manner.
In this study we utilized a PDMS based platform to investi-
gate the effect of stiffness on primary astrocyte function. This
approach has several advantages over the previously mentioned
methods including ease of replication, uniformity of injury and
ability to mimic mechanical properties of brain microenviron-
ment in different disease states. PDMS is a biocompatible,
stable and tunable material which provides a platform with
uniform mechanical properties. The uniform mechanical
properties induces a homogeneous population of “injured”
cells which can be assessed for molecular changes resulting
from mechanical stiffness. PDMS is chemically inert but can be
uniformly modied with PLL, a standard culture dish coating
for neural cells, to facilitate astrocyte attachment. This allows
for a uniform chemical coating which assures that change in
cellular phenotype is solely the result of platform mechanical
stiffness.
We employed a so substrate (200 Pa) to represent healthy
brain tissue and stiff substrate (8000 Pa) to represent diseased
brain tissue. These values were chosen due to the following
reasoning: (1) the elastic modulus of healthy rat and porcine
brain has been measured via indentation techniques and found
to fall in the range of 100 to 400 Pa,31,66 and (2) it has been
suggested that the changes in local mechanical properties may
play a role in disease pathology, thus we utilized a PDMS plat-
form of greater stiffness (8000 Pa) to determine if altering the
physical forces on the cellular level solely prompts the onset of
astrogliosis. Although tissue maturity and some neurodegen-
erative diseases have been shown to decrease the overall tissue
stiffness several injury and disease states, such as metastatic
tumor, stroke and traumatic brain injury, have been observed to
signicantly increase tissue stiffness.3,4,7,67–69
The successful induction of astrogliotic phenotype by this
model serves to provide preliminary information on the
phenotypic changes of astrocytes due to local alteration of
microenvironmental stiffness in vitro. We observed that astro-
cytes grown on so substrates displayed a consistently more
quiescent phenotype while those on stiff substrates displayed
astrogliosis-like phenotype. Georges and coworkers demon-
strated that neurons have consistent actomysin formation
regardless of surface stiffness while astrocytes demonstrated
mechanosensitivity by increased polarization on stiff surfaces.33
Prager-Khoutorsky and coworkers demonstrated that human
broblasts also showed similar changes in morphology pos-
sessing smaller, rounded morphology in so substrates and
elongated morphology with large focal adhesion points in stiff
substrates.70 Overall our data supports the hypothesis that
reactive morphology is induced by increased surface stiffness.
Primary astrocytes cultured on stiff substrates demonstrated
signicant increase in common hallmarks for astrogliosis –
glial brillary acidic protein (GFAP) protein expression and
proliferation. Previous studies have shown that astrocytes
devoid of GFAP expression are unable to accomplish the reac-
tive phenotype in injury and disease.45,71 This is the rst stiff-
ness induced astrogliosis model to quantify a cellular increase
in GFAP protein expression although stretch, hyperthermia and
chemically induced models of astrogliosis have all observed
similar up-regulation post injury.62,63,72 Previous models have
utilized GFAP staining to identify astrocyte populations and
quantify cell numbers on so and stiff polyacrylamide (PA) gels
but have not quantied protein expression. These studies
utilized GFAP staining to indicate an increased presence of
astrocytes on stiff surfaces attributing this to difficulty of
astrocytes to attach and grow on so polyacrylamide (PA)
gels.33,73 Georges et al. quantied the difference in adhesion by
counting the number of cells attached to so (200 Pa) and stiff
(9000 Pa) surfaces at 4 and 24 h of culture. They noted a slightly
higher number of astrocytes at 4 h compared to 24 h suggesting
a time dependent cell detachment from the so surfaces not
observed on stiff surfaces.33 Furthermore, Jiang and coworkers
quantied the number of mature astrocytes attached to so
(300 Pa) vs. stiff (27 and 230 kPa) PA gels by counting GFAP
positive astrocytes and found a signicantly higher number of
adherent astrocytes on stiff PA gels.73Our results suggest that an
increase in astrocyte number in our model on stiff surfaces is
dependent on induction of proliferation by the per cell analysis
of BrdU incorporation in astrocyte DNA. Our observations
support the hypothesis that the increase in culture surface
stiffness induces a reactive phenotype in astrocytes.
Our study observed that astrocytes on stiff disease-like
surface also resulted in increased ROS production and anti-
oxidant CuZnSOD activity. This is akin to the observation in
animal studies that have demonstrated chronic neuorin-
ammation and neurodegeneration associated with massive/
prolong brain injury or astrocyte stress leading to uncon-
trolled release of ROS.50–52 Further, superoxide dismutase (SOD)
is an anti-oxidative species in eukaryotic cells which convert
superoxide radicals into hydrogen peroxide to prevent oxidative
stress and damage in the presence of increased ROS generation.
The most important parameter determining biological impact
of SOD is the enzyme anti-oxidant activity with copper–zinc SOD
(CuZnSOD) constituting approximate 90% of all SOD activity in
eukaryotic cells.55 Our results show that reactive astrocytes
induced by mechanical stiffness experience an increase in ROS
generation and increase in CuZnSOD activity suggesting that
the oxidative state of reactive astrocytes is changed from those
of quiescent astrocytes as they adapt to the increased stress
from varied microenvironment. To our knowledge, no study has
specically investigated and demonstrated a role of stiffness in
regulation of ROS levels in astrocytes. Since varied oxidative
state is a commonly observed mechanism in disease these
results indicate our platform lends itself for investigation of
potential therapeutic strategies manipulating oxidative state
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during brain injury focusing on the intricate brain
microenvironment-astrocytes signaling pathways.
Previtera and coworkers demonstrated that the global
glutamate concentration of mixed cultures do not change
between so and stiff surfaces when the ratio of neurons to
astrocytes were similar however when the ratio of neurons was
higher than that of astrocytes the global concentration of
glutamate increased suggesting that the number of astrocytes is
key to the global concentration of glutamate.74 Jiang and
coworkers showed that neurons in mixed cultures were much
less susceptible to excitotoxicity on stiffer gels.73 This resistance
is attributed to an increased number of astrocytes on the stiff
environment compared to soer substrates. Our results are in
agreement with these studies and provide insight that increased
number of astrocytes may be needed to prevent glutamate
toxicity as the capacity of individual astrocytes to uptake
glutamate is decreased on stiff surfaces. Furthermore, to probe
why there is an observed loss in glutamate uptake we quantied
the gene expression of glutamate transporters. Our results
observed no change in GLAST expression and a signicant
increase in GLT1 gene expression on the stiff surface suggesting
that the loss in function is not a result of decreased gene
expression. Furthermore, GLAST and GLT1 protein expression
was unchanged on the 8000 Pa surface compared to the 200 Pa
surface. This indicates that the loss in glutamate uptake is
unrelated to the amount of glutamate transporters expressed
and therefore must lie in some other mechanism. To uncover
the root of glutamate homeostasis perturbation it would be
benecial to observe other factors inuencing transporter
function, energy metabolism and mitochondrial health. This
may be an informative future work of mechanistic discovery
utilizing this platform but is beyond the scope of the current
work. In the current study, we have demonstrated the potential
of our in vitro platform to emulate the onset of astrogliosis by
modeling the stiffness of brain in healthy and injury state. Our
platform recreates astrogliosis in vitro by inducing cellular
adaptation to increasing microenvironment stiffness. This
model can be used to facilitate understanding the role of
complex cell-microenvironment interactions that are hard to
dissect in clinical conditions of brain injury and neurodegen-
erative diseases.
In summary (Fig. 6), we demonstrated an innovative
approach to model astrogliosis on tunable substrates that
recreate the varying stiffness in brain mimicking healthy and
diseased state. This approach has several advantages over the
method used by other group including high delity, ease of
duplication, biocompatibility and ability to mimic brain
microenvironment in different disease states. We have
provided evidence that our platform emulates the various
clinical markers of astrogliosis by modulating the stiffness of
the substrate to correlate with normal (200 Pa) and injury (8000
Pa) conditions of brain microenvironment. To validate the
mimicry of the clinical conditions, we observed that astrocytes
grown on the healthy brain stiffness (200 Pa) displayed
a consistently more quiescent morphology as compared to
astrocytes cultured on stiff substrate (8000 Pa) that displayed
reactive morphology. Furthermore, we also demonstrated that
our model captured the changes in proliferation and GFAP
protein expression, clinical hallmarks for astrogliosis. We
demonstrated that astrocytes cultured on stiffer environment
resulted in increased ROS levels, CuZnSOD activity and loss in
glutamate uptake, thus compromising functional aspects of
astrocytes. This platform provides a robust system to compare
the temporal changes of astrocytes in the clinical markers and
functional aspects of the cells at the molecular level. Our model
can be utilized to investigate the intricate brain
microenvironment-astrocytes signaling pathways and possibly
lend to identifying new therapeutic strategies for brain injury.
Fig. 6 Schematic overview. By culturing on 200 and 8000 Pa PDMS culture surfaces primary astrocytes become activated on the stiff surface
with changed morphology, increased proliferation and increased GFAP protein expression. In the reactive phenotype induced by surface culture
stiffness astrocytes exhibit increased ROS, increased CuZnSOD activity and decreased glutamate uptake similar to reactive astrocytes in vivo.
Scale bar 100 mm.
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Supplemental Figure 1: PLL coating characterization on 200 Pa and 8000 Pa surfaces 
through images (A) and quantification of fluorescence using image J (B) reveals similar 
uniform coating on soft and stiff surfaces. Scale Bar 100 µm.  “*” P < 0.05
Supplemental Figure 2: RT-PCR gene expression quantification of Vimentin on soft 
and stiff surfaces, N = 3.  “*” P < 0.05
                    
Supplemental Figure 3. Representative images of the astrocyte culture. The astrocyte 
culture utilized for experiments was characterized by immunostaining with anti-glial 
fibrillary acidic protein (GFAP, red) and DAPI nuclear staining (blue). Cells were fixed 
with 4% paraformaldehyde for 20 min, permeabilized in 0.1% Triton X-100 for 15 min 
and background blocked with 1% bovine serum albumin (BSA) in PBS for 1 hr at room 
temperature. Cells were stained in primary antibody solution (1:1000 anti-GFAP [DAKO] 
in 1% BSA in PBS) at 4 °C overnight, secondary antibody solution (1:500 anti-Rabbit 
rhodamine [Millipore] in PBS) for 2 hr at room temperature and DAPI staining solution (1 
µg/ml DAPI in PBS) for 5 min at room temperature. Images were obtained using 
Axiovert 40 CFL [Zeiss] and images taken with a Progres C3 [Jenoptick] camera with an 
X-Cite series 120Q [Lumen Dynamics] lamp and a CY3 or DAPI filter [Chroma]. Culture 
purity was determined to be > 90 % astrocytes by counting the number of GFAP 
positive nuclei over the total nuclei using Image J cell counter, N = 8 images, Scale bar 
100 μm.
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